Table 1.
Rule-in and rule-out criteria from decision tree classification. When two criteria are stated, it is meant as a combined criterion. For the ADT group no rule-in criterion for PZ and no rule-out criterion for CG could be identified. The complementary two criteria are based on the TF Autocorrelation
| no-ADT | ADT | |||||||
|---|---|---|---|---|---|---|---|---|
| PZ | CG | PZ | CG | |||||
|
RULE-OUT
(100% healthy) |
T2w_mean | >133 | T2w_95perc | >204 | ADC_InvariantAutocorrelation | >0.645 | – | |
| OR | OR | |||||||
| T2w_mean & ADC_mean |
<133 >1.17 |
T2w_95perc & ADC_5perc |
<204 >0.84 |
|||||
|
RULE-IN
(100% tumor) |
T2w_mean &ADC_mean |
<133 <1.17 |
T2w_95perc &ADC_5perc |
<204 <0.84 |
– | ADC_InvariantAutocorrelation | <0.333 | |
ADC apparent diffusion coefficient, T2w T2 weighted magnetic resonance tomography, ADT androgen deprivation therapy, PZ peripheral zone, CG central gland